BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11432890)

  • 1. Late medical complications and fatigue in Hodgkin's disease survivors.
    Knobel H; Håvard Loge J; Lund MB; Forfang K; Nome O; Kaasa S
    J Clin Oncol; 2001 Jul; 19(13):3226-33. PubMed ID: 11432890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study.
    Hjermstad MJ; Fosså SD; Oldervoll L; Holte H; Jacobsen AB; Loge JH
    J Clin Oncol; 2005 Sep; 23(27):6587-95. PubMed ID: 16170166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.
    Hjermstad MJ; Oldervoll L; Fosså SD; Holte H; Jacobsen AB; Loge JH
    Eur J Cancer; 2006 Feb; 42(3):327-33. PubMed ID: 16377179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism.
    Kiserud CE; Seland M; Holte H; Fosså A; Fosså SD; Bollerslev J; Bjøro T; Loge JH
    Acta Oncol; 2015 Jan; 54(1):49-59. PubMed ID: 25140862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue.
    Ng AK; Li S; Recklitis C; Neuberg D; Chakrabarti S; Silver B; Diller L
    Ann Oncol; 2005 Dec; 16(12):1949-55. PubMed ID: 16227316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease survivors more fatigued than the general population.
    Loge JH; Abrahamsen AF; Ekeberg O; Kaasa S
    J Clin Oncol; 1999 Jan; 17(1):253-61. PubMed ID: 10458240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late complications after treatment of Hodgkin's disease].
    Lund MB; Kongerud J; Boe J; Ihlen H; Forfang K; Abrahamsen AF; Nome O
    Tidsskr Nor Laegeforen; 1999 Mar; 119(7):933-7. PubMed ID: 10210953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
    Rüffer JU; Flechtner H; Tralls P; Josting A; Sieber M; Lathan B; Diehl V;
    Eur J Cancer; 2003 Oct; 39(15):2179-86. PubMed ID: 14522376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications in children cured from Hodgkin's disease].
    Stachowicz-Stencel T; Bien E; Adamkiewicz-Drozynska E; Szolkiewicz A; Kuziemski K; Lass P; Stefanowicz J; Sierota D; Polczynska K; Birkholz D; Hennig M; Balcerska A
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):613-21. PubMed ID: 17317892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Sep; 3 Suppl 4():111-5. PubMed ID: 1450071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the thyroid in survivors of childhood Hodgkin's disease.
    Rodriquez DC; Guidoni E; D'ambrosio A; Pochiero F; Caini M; Guglielmucci D; Lucherini M; Carra F; Municchi G
    Minerva Pediatr; 2014 Aug; 66(4):249-56. PubMed ID: 25198559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmalignant complications of therapy for Hodgkin's disease.
    Hohl RJ; Schilsky RL
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):331-43. PubMed ID: 2663831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
    Eikeland SA; Smeland KB; Simensen VC; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
    Acta Oncol; 2023 Jan; 62(1):80-88. PubMed ID: 36715320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of chronic fatigue in Norwegian cervical cancer survivors.
    Steen R; Dahl AA; Hess SL; Kiserud CE
    Gynecol Oncol; 2017 Sep; 146(3):630-635. PubMed ID: 28552254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms.
    Loge JH; Abrahamsen AF; Ekeberg O; Kaasa S
    Ann Oncol; 1999 Jan; 10(1):71-7. PubMed ID: 10076725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study.
    Oldervoll LM; Loge JH; Kaasa S; Lydersen S; Hjermstad MJ; Thorsen L; Holte H; Jacobsen AB; Fosså SD
    BMC Cancer; 2007 Nov; 7():210. PubMed ID: 17997822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.